High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.

Abstract

Autotransplants increasingly are used to treat breast cancer. One-hundred-day mortality has decreased substantially. Three-year survival is better in women with earlier stage disease and in those who respond to pretransplant chemotherapy.